Geode Capital Management LLC Lowers Holdings in Bath & Body Works, Inc. $BBWI

Geode Capital Management LLC trimmed its position in shares of Bath & Body Works, Inc. (NYSE:BBWI) by 2.0% during the second quarter, HoldingsChannel reports. The fund owned 3,688,754 shares of the company’s stock after selling 73,745 shares during the quarter. Geode Capital Management LLC’s holdings in Bath & Body Works were worth $110,534,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other institutional investors also recently added to or reduced their stakes in BBWI. Summit Investment Advisors Inc. acquired a new stake in shares of Bath & Body Works in the 1st quarter valued at approximately $1,292,000. Mitsubishi UFJ Trust & Banking Corp grew its holdings in Bath & Body Works by 126.3% during the second quarter. Mitsubishi UFJ Trust & Banking Corp now owns 271,727 shares of the company’s stock worth $8,141,000 after acquiring an additional 151,668 shares during the period. IFM Investors Pty Ltd purchased a new position in Bath & Body Works in the first quarter worth $1,314,000. Amundi lifted its holdings in Bath & Body Works by 382.1% in the first quarter. Amundi now owns 174,951 shares of the company’s stock valued at $4,872,000 after acquiring an additional 138,664 shares during the period. Finally, Nuveen LLC purchased a new stake in shares of Bath & Body Works during the 1st quarter worth $23,273,000. Hedge funds and other institutional investors own 95.14% of the company’s stock.

Bath & Body Works Price Performance

BBWI stock opened at $15.83 on Friday. The company’s 50 day simple moving average is $24.83 and its 200-day simple moving average is $28.25. The firm has a market capitalization of $3.26 billion, a PE ratio of 4.70, a P/E/G ratio of 0.86 and a beta of 1.53. Bath & Body Works, Inc. has a 12 month low of $15.43 and a 12 month high of $41.87.

Bath & Body Works (NYSE:BBWI) last issued its quarterly earnings data on Thursday, November 20th. The company reported $0.35 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.40 by ($0.05). Bath & Body Works had a negative return on equity of 48.43% and a net margin of 9.88%.The company had revenue of $1.59 billion for the quarter, compared to analyst estimates of $1.64 billion. During the same quarter in the prior year, the firm earned $0.49 earnings per share. The company’s revenue for the quarter was down 1.0% on a year-over-year basis. Bath & Body Works has set its FY 2025 guidance at 2.870- EPS. Q4 2025 guidance at 1.700- EPS. As a group, sell-side analysts anticipate that Bath & Body Works, Inc. will post 3.3 earnings per share for the current year.

Bath & Body Works Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, December 5th. Stockholders of record on Friday, November 21st will be given a $0.20 dividend. This represents a $0.80 annualized dividend and a dividend yield of 5.1%. The ex-dividend date is Friday, November 21st. Bath & Body Works’s dividend payout ratio is currently 23.74%.

Analysts Set New Price Targets

BBWI has been the subject of a number of research analyst reports. Wells Fargo & Company cut their price target on shares of Bath & Body Works from $44.00 to $33.00 and set an “overweight” rating for the company in a report on Monday, October 27th. The Goldman Sachs Group lowered shares of Bath & Body Works from a “buy” rating to a “neutral” rating and set a $17.00 target price on the stock. in a research report on Thursday. Telsey Advisory Group reaffirmed an “outperform” rating and issued a $38.00 target price on shares of Bath & Body Works in a report on Thursday. Raymond James Financial reissued a “market perform” rating on shares of Bath & Body Works in a research note on Wednesday, November 12th. Finally, Weiss Ratings restated a “hold (c-)” rating on shares of Bath & Body Works in a report on Wednesday, October 8th. Ten analysts have rated the stock with a Buy rating and eight have issued a Hold rating to the stock. Based on data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average price target of $34.17.

Bath & Body Works Company Profile

Bath & Body Works, Inc is a specialty retailers and home to America’s Favorite Fragrances, offering a breadth of exclusive fragrances for the body and home, including the selling collections for fine fragrance mist, body lotion and body cream, 3-wick candles, home fragrance diffusers and liquid hand soap.